GovChime
Notice ID: 1088da20664a4b0991776e0cc2f19389Award NoticeAwardedArchived

6505--Radiopharmaceuticals | VA San Diego | Base Year

Awarded on December 10, 2025. Full description on SAM.gov.

Awarded tounder 36C26226D0036 (source: SAM.gov award notice)• $320.3K

Overview

Posted
December 10, 2025
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of Veterans Affairs

Notice details

Office
262-NETWORK CONTRACT OFFICE 22 (36C262)
Place of performance
Department of Veterans Affairs VA San Diego Healthcare System, San Diego, CA, 92161
Last updated
Nov 5, 2026
First published
Last updated on SAM.gov
Award date
Dec 10, 2025
Award amount (SAM.gov award notice)
$320.3K

Identifiers

Solicitation number
36C26226Q0072
Notice ID
1088da20664a4b0991776e0cc2f19389
Award number (PIID)
36C26226D0036

Description

This amendment (002) for solicitation 36C26226Q0072 shall: Extend the response time to 11/21/2025 at 10:00 AM PT local time. Modify the estimated minimum quantities. Add line item I-131 USP NaI TX cap per mCi (30mci). Change period of performance. Increase estimated maximum dollar value. Est. Min Order Dollar Value Est. Maximum Dollar Value Base Year $100,000.00 $800,000.00 Period of Performance Base Year 12/12/2025 12/11/2026 Description Estimated Min Quantity UOM Unit Price I-123 USP NaI 200 uCi capsules 45 EA I-123 Iobenguane Sulfate (I-123 Adreview MIBG) 1 EA I-131 USP NaI DX cap per mCi (4mci) 10 EA I-131 USP NaI TX cap per mCi (30mci) 10 I-131 USP NaI TX cap per mCi (150mci) 13 EA In-111 Pentetreotide (Octertide/Octeoscan) UD 1 EA In-111 Pentetate (DTPA) SDV/Vial 1 EA In-111 Autologuous WBCs tagging, pick-up and delivery 13 EA In-111 WBC Blood Kit (Heparin) 13 EA 99mTc Mertiatide (MAG3) UD 35 EA 99mTc Sulfur colloid UD ( Filtered ) 9 EA 99mTc Sulfur colloid UD 90 EA 99mTc Macro Aggregated Albumin (MAA) UD 180 EA 99m Tc Pentetate (DTPA)UD 170 EA 99mTc dimercaptosuccinic acid (DMSA) UD 1 EA 99mTc Medronate (MDP) UD 400 EA 99mTc Sestamibi (Cardiolite®) UD DO NOT SUBSTITUTE 3900 EA 99mTc NaTco4 UD per mCi 30 EA 99mTc Mebrofenin (Choletec)UD 30 EA Ga-67 Gallium Citrate UD 1 EA GA-68 DOTATATE 30 EA Macro Aggregated Albumin Vial 0 EA Pentetate Vial 0 EA Medronate Vial 0 EA Ultra-tag kit 0 EA Standard scheduled delivery 3-4 per/day Stat Delivery Service (within 1 hour) available 24 hours/day 8 EA After hours call out 4 EA TOTAL $ All other terms and conditions remain unchanged.

Full description on SAM.gov

Award Overview

Award Number

36C26226D0036

Award Amount (SAM.gov award notice)

$320.3K

Award Date

Dec 10, 2025

Awardee

Awardee UEI

UA3GDUKRYSM5

Awardee CAGE Code

8JQE2

Awardee Address

LAKE MARY, FL 32746, FALKLAND ISLANDS (ISLAS MALVINAS)

Line Item Number

1

Original Solicitation

Notice ID: 1088da20664a4b0991776e0cc2f19389

Posted Date: Dec 10, 2025

Original Response Deadline: Not specified

Task Orders Under This IDV

Top 10 by total obligated

3
  • 36C26226N0235
    RLS (USA) INC.
    Department of Veterans AffairsNAICS 325412
    $323.0KSigned Nov 6, 2026
  • 36C26226N0235
    RLS (USA) INC.
    Department of Veterans AffairsNAICS 325412
    $323.0KSigned Dec 10, 2025
  • 36C26226N0235
    RLS (USA) INC.
    Department of Veterans AffairsNAICS 325412
    $323.0KSigned Feb 11, 2026

More From This Vendor

Top 5 most recent

5
  • 36C26125N0286
    RLS (USA) INC.
    Department of Veterans AffairsNAICS 325412
    $208.8KSigned Nov 8, 2026
  • 36C26226N0235
    RLS (USA) INC.
    Department of Veterans AffairsNAICS 325412
    $323.0KSigned Nov 6, 2026
  • 36C26025P1184
    RLS (USA) INC.
    Department of Veterans AffairsNAICS 325412
    $94.6KSigned Oct 21, 2026
  • 36C24724C0063
    RLS USA INC
    Department of Veterans AffairsNAICS 325412
    $2.1MSigned Oct 13, 2026
  • 36C25627D0016
    RLS (USA) INC.
    Department of Veterans AffairsNAICS 325412
    —Signed Oct 1, 2026

Contacts

Contracting Officer

Primary Contact

Adrienne Brown
Contracting Officer

Documents

Files (4)

  • 36C26226Q0072 0002.docx

    20 KBAdded in Combined Synopsis/Solicitation version 5Posted
    Download
  • 36C26226Q0072 0001.docx

    15 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download
  • 36C26226D0036_1.docx

    22 KBAdded in Award Notice version 5Posted
    Download
  • 36C26226Q0072_1.docx

    74 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download

Lifecycle

  1. 3
    Version 3Combined Synopsis/SolicitationArchived

    6505--Radiopharmaceuticals | VA San Diego | Base Year

    Notice c1579d5054404e048caa5c756d637108 on SAM.gov

  2. 5
    Version 5Award NoticeArchivedCurrent

    Type changed from Combined Synopsis/Solicitation to Award Notice

    6505--Radiopharmaceuticals | VA San Diego | Base Year

    Notice 1088da20664a4b0991776e0cc2f19389 on SAM.gov

Other notices for this solicitation

  1. Combined SynopsisRelated noticeNov 5, 2025

    6505--Radiopharmaceuticals | VA San Diego | Base Year

    Notice c69845d45b8945138e43ef53d3d44b58 on SAM.gov

  2. Combined SynopsisRelated noticeNov 7, 2025

    6505--Radiopharmaceuticals | VA San Diego | Base Year

    Notice f8c1d14156d04af3aff06035c2329fbe on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
THIS REQUEST FOR INFORMATION (RFI) / SOURCES SOUGHT NOTICE IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES. THIS IS NOT A SOLICITATION. SUBMISSION OF INFORMATION ABOUT PRICING, DELIVERY, THE MARKET, AND CAPABILITIES IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI FOR PLANNING PURPOSES IN ACCORDANCE WITH (IAW) FAR 15.201(e). DISCLAIMER This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. SOURCES SOUGHT/RFI DESCRIPTION This is NOT a solicitation announcement. This is a Sources Sought Notice / RFI only. The purpose of this Sources Sought Notice / RFI is to gain information about potential qualified sources and their size classification relative to NAICS 325412 (size standard of 1,300 Employees). Responses to this Sources Sought Notice / RFI will be used by the Government to make appropriate acquisition decisions. After review of the responses to this Sources Sought Notice / RFI, further RFIs and/or a solicitation or other announcements may be published. STATEMENT OF WORK Manufacturing and delivery of sterile/aseptic, USP 825 compliant, low enriched uranium (LEU) radiopharmaceuticals for diagnosis and treatment of patients receiving services at VA San Diego Healthcare System Nuclear Medicine Service. Delivery services must meet all DOT requirements for shipment and delivery of radioactive drugs. Stat delivery services (within 1 hour) must be available 24hrs/day 365 days/year. Companies providing services must provide dose labels compatible with the Nuclear Medicine information System (NMIS) computerized radiopharmacy database. Companies must provide storage, preparation, labeling and delivery of research radiopharmaceuticals as requested. Base January 1, 2027, through December 31, 2027 OY 1 January 1, 2028, through December 31, 2028 OY 2 January 1, 2029, through December 31, 2029 OY 3 January 1, 2030, through December 31, 2030 OY 4 January 1, 2031, through December 31, 2031 PARTICIPATING VA HEALTHCARE SYSTEMS: VA San Diego Healthcare System 3350 La Jolla Village Drive Nuclear Medicine Service San Diego, CA 92161 2. ROUTINE ORDERS Routine orders require delivery the next business day, unless specified elsewhere in this contract. 3. EMERGENCY ORDERS Stat delivery services (within 1 hour) must be available 24hrs/day 365 days/year. 4. PRICE/COST SCHEDULE Description Estimated Min Quantity UOM Unit Price I-123 USP NaI 200 uCi capsules 35 EA I-123 USP NaI 2 mCi 3 EA I-123 USP NaI 4 mCi 3 EA I-123 Iobenguane Sulfate (I-123 Adreview MIBG) 1 I-131 USP NaI DX cap per mCi (4mci) 10 EA I-131 USP NaI TX cap per mCi (150mci) 10 EA In-111 Pentetreotide (Octertide/Octeoscan) UD 1 EA In-111 Pentetate (DTPA) SDV/Vial 1 EA In-111 Autologuous WBCs tagging, pick-up and delivery 9 EA In-111 WBC Blood Kit (Heparin) 9 EA 99mTc Mertiatide (MAG3) UD 38 EA 99mTc Sulfur colloid UD ( Filtered ) 10 EA 99mTc Sulfur colloid UD 90 EA 99mTc Macro Aggregated Albumin (MAA) UD 220 EA 99m Tc High Concentrated (Technegas) 25mCi 150 EA 99m Tc Pentetate (DTPA)UD 1 EA 99mTc dimercaptosuccinic acid (DMSA) UD 1 EA 99mTc Medronate (MDP) UD 300 EA 99mTc Sestamibi (Cardiolite®) UD DO NOT SUBSTITUTE 3400 EA 99mTc PYP or (HDP) 50 EA 99mTc NaTco4 UD per mCi 30 EA 99mTc Mebrofenin (Choletec)UD 25 EA Tl-201 Thallious Chloride UD 1 EA Ga-67 Gallium Citrate UD 1 EA GA-68 DOTATATE (NET-SPOT) 15 EA Macro Aggregated Albumin Vial 0 Pentetate Vial 0 EA Medronate Vial 0 EA Ultra-tag kit 4 Hep-lock for RBC Tag 4 Standard scheduled delivery 3-4 per/day  Stat Delivery Service (within 1 hour) available 24 hours/day 8 After hours call out 4 Heparin vial 4 Heparin/Hetastarch Syringe 9 TOTAL 5. DELIVERY LOCATION, NORMAL WORK HOURS AND INSTRUCTIONS: Delivery Location Nuclear Medicine Service, Main Hospital, 4 West, 4th Floor Normal Work Hours 7:00am to 4:00pm, Monday through Friday 6. PACKAGING AND MARKING a) The contractor shall package, mark and transfer all radioactive material in accordance with all applicable local, state, and federal regulations. b) Items must be properly packaged to prevent damage during shipping, handling, and storage. c) All outer packages must contain the complete purchase number, obligation number and contract number in addition to the shipping address. The purchase number and obligation number will be provided by the individual at the time of ordering. The contract number will be provided upon notice of contract award. d) Packaging List: A packing list/slip shall be enclosed with each shipment indicating the purchase/obligation and delivery order number, contract number, items/quality ordered, and items/quality shipped. 7. RECALLED AND DEFECTIVE PRODUCTS The Contractor will immediately notify the Contracting Officer of any recalls of product or other important product safety issues. As appropriate, the Contractor will replace and/or reimburse recalled / defective products at no cost to the Government. The Contractor may be liable for costs of processing recalls, i.e. administrative and clinical services to replace recalled / defective products. 8. SAFETY GUIDELINES AND REQUIREMENTS The Contractor shall perform all functions of the contract in compliance with Occupational Safety and Health Administration (OSHA), FDA, NRC, Joint Commission safety guidelines and Department of Transportation (DOT) requirements. The Contractor shall self-report any violations to the point of contact (POC) within twenty-four (24) hours. Delivery personnel shall be trained in Radiation Safety Techniques, Nuclear Regulatory Commission, Joint Commission safety guidelines and Department of Transportation requirements. 9. NATIONAL HOLIDAYS OBSERVED BY THE GOVERNMENT New Year s Day January 1 Martin Luther King s Birthday 3rd Monday in January Presidents Day 3rd Monday in February Memorial Day Last Monday in May Juneteenth June 19 Independence Day July 4 Labor Day 1st Monday in September Columbus Day 2nd Monday in October Veterans Day November 11 Thanksgiving Day 4th Thursday in November Christmas Day December 25th The President of the United States of America may declare additional days as a federal holiday, and if so, this holiday will automatically be added to the list above. When a holiday falls on a Sunday, the following Monday shall be observed as a Federal holiday. When a holiday falls on a Saturday, the preceding Friday shall be observed as a Federal Holiday. 10. CONTRACTOR DELIVERY PERSONNEL All contractor personnel are required to wear clothing bearing the name of the Contractor and wear a badge that has the Contractor name. Contractor personnel must have a picture I.D. and must be able to speak English. 11. PARKING AND SPEED LIMIT Park only in areas designated by the Contracting Officer Representative (COR) or otherwise directed by Police and Security Service personnel. The Contractor shall display on each of its vehicles the company name in a size that is clearly visible. Upon receipt of award, the Contractor shall submit a list of employees and vehicles to the COR of each facility. The Contractor shall conform to the speed limit set at each Government facility. Should Contractor personnel receive a citation for parking, speeding or other infraction from VA Security, the offenses will be handled in Federal Court as they are Federal offenses. 12. INVOICE AND PAYMENT No advanced payments will be authorized. The contractor shall submit invoices monthly. The invoice must have at a minimum, the contract number, assigned purchase order, assigned obligation number, date order was placed, date order was shipped, and any additional necessary detailed information to identify service rendered. Payment on invoice may be delayed in invoice(s) are not completed properly. NOTE: Potential quoters must be aware that the items being acquired are procured as Brand Name or Equal. For those items that are or equal , a description of the salient characteristics is outlined below. It is quoter s responsibility to demonstrate its quote meeting the salient physical and functional characteristics included in this solicitation. If the quote does NOT demonstrate, the offer will be considered non-responsive. The interested parties bear full responsibility to ensure their submission demonstrates to the government that they can satisfy the requirement by providing the brand name or equal to the supplies being requested. VAAR 852.212-71 Gray Market and Counterfeit Items clause applies on this acquisition. No remanufacturers or gray market items will be acceptable. Vendor shall be an Original Equipment Manufacturer (OEM), authorized dealer, authorized distributor or authorized reseller verified by an authorization letter or other documents from the OEM signed. The letter must either state specific product(s) quoted or that the quoter is an authorized distributor for all the manufacturer s products. This letter must be on the manufacturer s letterhead and contains the signature of an authorized official for the manufacturer. If the interested contractor fails to provide a signed letter from the OEM (unless the contractor is the OEM), the contractor s response will be deemed non-responsive and will not be considered for award. The list of DRAFT characteristics is intended to be descriptive, not restrictive, of the supplies/services that are required. If your company is interested and capable of providing the required supplies/services, please provide the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions: (1) Submit your capabilities statement illustrating how your organization can/cannot meet the list of SOW requirements. For instances where your company cannot meet the SOW requirement(s), please explain. For instances where your company can meet the SOW requirement(s), please show how your company meets/exceeds each requirement. (2) Please review the list of SOW requirements and provide any additional feedback or suggestions. If none, please reply as N/A. (3) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc. (4) Is your company considered small under the NAICS code identified in this RFI? (5) Are you the manufacturer, authorized distributor, and/or can your company provide a solution to the required supplies/services described in the list of SOW? (6) If you are a large business, do you have any designated/authorized distributors? If so, please provide their company name, telephone, point of contact and size status (if available). (7) If you re a small business and you are an authorized distributor/reseller for the items identified above, do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified. (8) Limitations on Subcontracting: How does your business ensure compliance with the limitations on subcontracting as outlined in 13 CFR § 125.6? (9) Are the items you are identifying/providing considered Commercial of the Shelf (COTS) items as defined in FAR Part 2.101 under commercial items? (10) Non-Manufacturer Rule: If applicable, can you confirm your business complies with the Non-Manufacturer rule? Specifically, does your company: Provide a product from a small business manufacturer or processor? Not exceed 500 employees? Primarily engage in the retail or wholesale trade and normally sell the type of item being supplied? Take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice? (11) Please indicate whether your product conforms to the requirements of the Buy American Act? (12) Does your company have a Federal Supply Schedule (FSS) GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract? If so, please provide the contract number(s). (13) If you are an FSS GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract holder, are all the items/solutions you are providing information about available on your schedule/contract? Please state if all or some items are available on the contract. (14) General pricing of your products/solution is encouraged. Pricing will be used for the purpose of market research only. It will not be used to evaluate for any type of award. (15) Please provide your SAM.gov Unique Entity ID/Cage Code number. Responses to this notice shall be submitted via email to Adrienne.Brown4@va.gov. Telephone responses will not be accepted. Responses must be received no later than Friday, November 6, 2026, by 10AM Mountain Time. All responses to this Sources Sought/RFI will be used for planning purposes only. Responses to this Sources Sought Notice / RFI are not considered a request to be added to a prospective bidders list or to receive a copy of the solicitation. If further RFIs and/or a solicitation or other announcement is issued as a result of the information provided from this RFI, all interested parties must respond to the specific posting separately IAW the specifications of that announcement.
100%
Market Research11/06/2026
Sources sought notice for VISN 2 Downstate General Radiopharmaceuticals.
84%
Market Research11/17/2026
SOURCES SOUGHT NOTICE (36C25027Q0052) Low Energy Radiopharmaceuticals (Non-FDG F-18 Agents), Unit Doses VA Northeast Ohio Healthcare System (Cleveland, OH) and VA Kent Imaging and Infusion Center (Kent, OH) Notice Type: Sources Sought (Market Research Only) Contracting Office: Department of Veterans Affairs NAICS Code: 325412 Pharmaceutical Preparation Manufacturing Small Business Size Standard: 1,300 employees Product Service Code (PSC): 6505 Drugs and Biologicals Place of Performance: Hot Lab Room B-C432, 10701 East Blvd., Cleveland, OH 44106; and Hot Lab Room B109, 3838 Cascades Blvd., Kent, OH 44240 Anticipated Period of Performance: Base: 01/01/2027 12/31/2027, plus four (4) 12-month option years (through 12/31/2031) Response Due Date/Time: 9:00 AM Eastern Time, Tuesday, November 3, 2026 to: Robert.Blasko@va.gov 1. PURPOSE / DISCLAIMER This is a Sources Sought Notice (SSN) issued for market research purposes only in accordance with FAR Part 10. It is NOT a solicitation, a request for proposal, a request for quotation, or an invitation for bid, and it does not commit the Government to issue a solicitation or award any contract. The Government will not pay for any information submitted in response to this notice, and responses will not be returned. Submitting a response does not guarantee participation in any future solicitation. The purpose of this notice is to identify qualified sources including the extent of participation by Service-Disabled Veteran-Owned Small Businesses (SDVOSBs), Veteran-Owned Small Businesses (VOSBs), and other small business concerns capable of meeting the requirement described below. Responses will assist the Government in determining the appropriate acquisition strategy (including any Veterans First / Rule of Two set-aside determination under VAAR 819.70) and will be used to support acquisition planning under FAR Part 10 and VAAR Part 810. This requirement is being conducted under the VA's health-care-resources sharing authority at 38 U.S.C. 8153 and Public Law 104-262. 2. BACKGROUND AND SCOPE The VA Northeast Ohio Healthcare System and the VA Kent Imaging and Infusion Center require unit-dose, patient-specific low energy radiopharmaceutical products (non-fluorodeoxyglucose F-18 agents) to support routine (non-emergent) and emergent diagnostic nuclear medicine imaging and limited therapeutic procedures. All doses must be compounded and calibrated by or under the supervision of a certified Nuclear Pharmacist and prepared within the required guidelines of the Board of Pharmacy, specifically USP and USP as appropriate. The contractor must follow generally accepted industry standards and the regulations of the applicable governing bodies, which may include the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the Food and Drug Administration (FDA), the Nuclear Regulatory Commission (NRC), the Centers for Disease Control and Prevention (CDC), the United States Pharmacopeia (USP), and The Joint Commission (JC). Delivery requirement: The contractor must support both routine and emergent orders (Emergencies). Emergencies may be requested during and outside of regular work hours (Monday through Friday, 06:30 a.m. 4:30 p.m.) and require delivery within 120 minutes after receipt of a phoned, faxed, or electronic order from the VA. The VA also requires prompt processing of Tc-99m tagged white blood cell (WBC) orders. Quantities are estimates and may vary based on patient demand. 3. REQUIRED LICENSURE STATEMENT Interested parties must already possess all licenses, registrations, and authorizations required to receive, possess, compound, prepare, transport, distribute, and dispose of the radioactive byproduct material / radiopharmaceutical isotopes described in this notice, and must be regularly established in the business of providing radionuclides. At a minimum, respondents must hold a current, unrevoked Nuclear Regulatory Commission (NRC) and/or applicable Agreement State radioactive materials license authorizing production and distribution of radiopharmaceuticals for human administration, and the authority to receive and dispose of radioactive waste, together with all applicable FDA, U.S. Department of Transportation (DOT), and state and local authorizations. Respondents should confirm they currently hold such licensure (and, where applicable, identify the issuing authority and license type) as part of their response. Respondents are not required to submit the full license with this SSN but must affirmatively state that current, valid licensure is in place; copies may be required at the solicitation/award stage. 4. ESTIMATED REQUIREMENT (ANNUAL ESTIMATES) The following unit-dose radiopharmaceutical products are required. Quantities are annual estimates based on historical usage for one year and may vary based on patient demand. Item Description Est. Annual Qty 1 99mTc Sulfur Colloid 320 2 99mTc MDP 850 3 99mTc Mebrofenin 110 4 99mTc MAG-3 80 5 99mTc Tetrofosmin 10 6 99mTc MAA 75 7 111In Pentreotide 2 8 99mTc04- (Sodium Pertechnetate) 90 9 99mTc Sestamibi 5,000 10 99mTc White Blood Cell Labeling 90 11 111In White Blood Cell Labeling 2 12 99mTc DTPA 30 40 mCi 60 13 99mTc DTPA 0.4 0.7 mCi 5 14 I-123 Iodine Capsules 200 microcuries 90 15 I-123 Iodine Capsules 2 5 millicuries 12 16 UltraTag Kit 22 17 99mTc Filtered Sulfur Colloid: 0.5 1 millicurie 6 18 123I MIBG dose 2 19 Cold PYP vials 50 20 99mTc PYP 100 21 99mTc DMSA 2 22 67Ga Gallium Citrate 2 23 111In DTPA 2 24 99mTc HMPAO 2 25 131I Diagnostic capsule 10 26 131I Therapeutic capsule 1 3 mCi 12 27 131I Therapeutic capsule, each additional mCi 1,500 28 99mTc HDP 55 29 99mTc WBC Blood Kit (Heparin) 90 Products must be labeled with the radiopharmaceutical identity, amount/activity, concentration, preparation time, calibration time, total volume, expiration date and time, and must include a bar-code label to facilitate scanning into a Nuclear Medicine Information System (NMIS). Each syringe, vial, syringe shield, and vial shield must be correctly labeled. 5. INFORMATION REQUESTED FROM RESPONDENTS Interested and capable firms are invited to submit a response demonstrating their ability to meet this requirement. Responses must include ALL of the following: Manufacturer Authorized Distribution Letter(s) documentation establishing the respondent's authorization to distribute the applicable radiopharmaceutical product(s) (e.g., authorized distributor/dealer letter(s) from the manufacturer(s)). Manufacturer's Name(s) identify the manufacturer(s) of the radiopharmaceutical product(s) the respondent would supply. Business Size and Socioeconomic Status state whether the firm is a large or small business under NAICS 325412 (1,300-employee size standard), and identify all applicable socioeconomic categories (e.g., SDVOSB, VOSB, 8(a), HUBZone, WOSB, SDB, or other). SDVOSBs/VOSBs must be certified in the SBA Veteran Small Business Certification program (via the SBA Search for Certified Businesses (SBS)). Ability to Provide ALL Items state clearly whether the firm can provide ALL of the items listed in Section 4. If the firm can provide only a portion, identify specifically which item(s) it can and cannot supply. GSA / NAC / SAC Availability state whether the item(s) are available on a GSA Schedule, a VA National Acquisition Center (NAC) contract, or a VA Strategic Acquisition Center (SAC) / MSPV contract vehicle, and provide the applicable contract number(s) if so. SAM Unique Entity Identifier (UEI) provide the firm's SAM.gov UEI. Respondents must be actively registered in SAM.gov (www.sam.gov). Current Licensure Confirmation an affirmative statement that the firm currently holds all required NRC and/or Agreement State, FDA, and DOT licenses/authorizations to receive, compound, prepare, transport, distribute, and dispose of the radiopharmaceutical isotopes described herein (see Section 3), including the issuing authority and license type where applicable. Positive Acknowledgement of Delivery Capability a positive, affirmative statement that the firm can deliver in accordance with ALL SOW requirements, including the ability to fulfill emergent orders within 120 minutes of receipt to both the Cleveland and Kent locations, and to provide unit doses compounded/calibrated by or under a certified Nuclear Pharmacist in accordance with USP / and all applicable NRC/FDA/DOT/state regulations. Respondents are encouraged to identify the location(s) of the radiopharmacy(ies) from which they would service both sites. Additional information requested (optional but helpful): company name, address, point of contact (name, title, phone, email); a brief capability statement; and any relevant prior experience providing unit-dose radiopharmaceuticals to federal or commercial healthcare customers. 6. SUBMISSION INSTRUCTIONS Response due date/time: 9:00 AM Eastern Time, Tuesday, November 3, 2026. Responses received after this date and time may not be considered. Format: Submit responses electronically to the Contracting Officer / Contract Specialist identified in the SAM.gov posting (Robert.Blasko@va.gov) . Reference this Sources Sought Notice number (36C25027Q0052) in the subject line. Page/content: Address each item in Section 5, in order. Capability statements should be concise. Questions: Direct any questions to the point of contact listed in the SAM.gov posting (Robert.Blasko@va.gov) prior to the response due date. 7. IMPORTANT NOTES This notice does not restrict the Government to any particular acquisition approach. Based on the responses received, the Government will determine whether the requirement can be set aside for SDVOSBs, VOSBs, or other small business concerns consistent with the Veterans First Contracting Program (VAAR 819.70) and the Rule of Two, or whether another acquisition strategy is appropriate. Respondents are advised that the Nonmanufacturer Rule (13 CFR 121.406) and Limitations on Subcontracting (FAR 52.219-14 / 52.219-33) apply to any resulting SDVOSB/VOSB set-aside or sole-source award above the micro-purchase threshold. Respondents should be prepared to address their status (manufacturer vs. nonmanufacturer) under these rules. All prospective offerors must be registered in SAM.gov to be eligible for any resulting award. The applicable Buy American Act / Trade Agreements Act provisions will apply to any resulting solicitation; respondents may be required to provide a Buy American Act certificate and country-of-origin information at the solicitation stage. THIS IS A SOURCES SOUGHT NOTICE / MARKET RESEARCH ONLY NOT A SOLICITATION.
80%
Market Research11/03/2026
THIS REQUEST FOR INFORMATION (RFI) / SOURCES SOUGHT NOTICE IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES. THIS IS NOT A SOLICITATION. SUBMISSION OF INFORMATION ABOUT PRICING, DELIVERY, THE MARKET, AND CAPABILITIES IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI FOR PLANNING PURPOSES IN ACCORDANCE WITH (IAW) FAR 15.201(e). DISCLAIMER This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. SOURCES SOUGHT/RFI DESCRIPTION This is NOT a solicitation announcement. This is a Sources Sought Notice / RFI only. The purpose of this Sources Sought Notice / RFI is to gain information about potential qualified sources and their size classification relative to NAICS 325412 (size standard of 1,300 Employees). Responses to this Sources Sought Notice / RFI will be used by the Government to make appropriate acquisition decisions. After review of the responses to this Sources Sought Notice / RFI, further RFIs and/or a solicitation or other announcements may be published. The Department of Veterans Affairs (VA) is seeking sources capable of providing 18-FDG, F18 NaF, and Bulk F-18 FDG. The list of DRAFT characteristics is intended to be descriptive, not restrictive, of the supplies/services that are required. STATEMENT OF WORK (SOW) Nuclear Medicine Radiopharmaceutical Supply for FDG dose supplies. General: The Department of Veterans Affairs Loma Linda Healthcare System Nuclear Medicine service intends to set up a single award Firm Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) Contract to procure radiopharmaceutical Supplies. Period of Performance: Base: 12/15/2026 12/14/2027 Option Year 1 (OY1): 12/15/2027 12/14/2028 Option Year 2 (OY2): 12/15/2028 12/14/2029 Option Year 3 (OY3): 12/15/2029 12/14/2030 Option Year 4 (OY4): 12/15/2030 12/14/2031 Deliverables: Item Description Base Estimated Qty OY1 Estimated Qty OY2 Estimated Qty OY3 Estimated Qty OY4 Estimated Qty 18-FDG 12 mCi per dose 240 240 240 240 240 F18 NAF 10 mCi 240 240 240 240 240 Bulk F-18 FDG US (30mCi max) 4 4 4 4 4 STAT Fees (if applicable) As needed As needed As needed As needed As needed The quantities cited above chart are estimated quantities for base and all option periods; quantities are not a contractual statement of precise quantities that the Government will order. The quantities given are estimated only, and no guarantee of their accuracy is either given or implied. The Government will only pay for quantities that are actually ordered and for which the services are fulfilled. Order Limitation Minimum Order per delivery order $10,000.00 Maximum Order per delivery order $350,000.00 Radioactive agents may be Injection, USP. Able to assay the dose in a suitable dose calibrator prior to administration. Must be a sterile dose for intravenous injection. Routine Orders: Routine orders require delivery on the next business day, unless specified elsewhere in this contract. Emergency Orders: Emergency delivery requires delivery on the same day and with the time specified during the placement of order. Delivery Location, Normal Work Hours, and Instructions: Time of delivery specified or mutually agreed to at the time of receipt of telephone orders shall become mandatory upon the Contractor s acceptance to commitment. Delivery of supplies by the scheduled time will be complete except as otherwise authorized by Government personnel. If the Contractor cannot make delivery and an outside source must be utilized, the Contractor will be responsible for paying the difference in cost. VA LOMA LINDA HEALTHCARE SYSTEM Delivery Location Nuclear Medicine Section, Imaging Service. Main hospital, 4th Floor, Room 4E15, Extension 2669 or 2672. Normal Work Hours 8:00am to 4:00pm, Monday through Friday Instruction 1) Delivery shall be next business day. Unit Dose Item: For unit-dose items, products shall be pre-drawn into a syringe, calibrated and delivered at time specified when ordered. The word Dose represents the maximum size potency per unit price; however, order may be less. Packaging and Marking: The contractor shall package, mark and transfer all radioactive material in accordance with all applicable local, state, and federal regulations. Items must be adequately packaged to prevent damage during shipping, handling, and storage. All outer packages must contain the complete purchase number, obligation number and contract number in addition to the shipping address. The purchase number and obligation number will be provided by the individual at the time of ordering. The contract number will be provided upon notice of contract award. Packaging List: A packing list/slip shall be enclosed with each shipment indicating the purchase/obligation and delivery order number, contract number, items/quality ordered, and items/quality shipped. The Contractor shall provide MSDS sheets (Material Safety Data Sheets) and updates as necessary on all delivered products. Quality Assurance: The quantity of radioactivity for supplied radiopharmaceuticals will not deviate more than + or 20% for imaging doses at the time of calibration, from the quantities specified. The Contractor will perform all quality control procedures on each radiopharmaceutical according to applicable requirements of licensing authorities and other regulating bodies. A copy of the results of the quality control procedures must be made available to VALLHCS upon request. In the event that a quality control or material defect is suspected and/or detected by the Contracting Officer Representative (COR), the Contractor will be requested to provide any consultation necessary to alleviate any said suspicion and/or defect by the following: Provide technical expertise in calibration. Provide professional examination of product; submit results and recommendations to the Contracting Officer. Make expedient replacement of any product suspected of being deficient. The Contractor shall make quality control records available to VALLHCS upon written request from the Contracting Officer The Contractor must provide waste disposal at no additional charge of used radioactive dose syringes, vials, etc.; unless otherwise stipulated or prohibited by licensure or regulatory requirements. The Contractor shall provide any additional technical support deemed necessary for the technical staff, physicians, and patient education. Any recalled dose for any reason shall be credited to the Government for the full amount. Any individual doses shall be traceable to the original elution if requested by the Government as per VISN 22 pharmacy standards and regulations. Any dose deemed below standard by the facility shall be credited toward the account. This shall be determined by the Authorized User or COR. Substitutions or Generic Brands may only be used with the express permission of the facility. Items must be bar-coded and be compatible with the existing NMIS System. The Contractor shall meet all requirements of regulatory agencies for deliveries of radioactive isotopes between facilities and shall strictly adhere to these requirements. Deliveries not properly handled according to regulations will not be accepted. The Contractor shall be responsible for all costs incurred for any radiopharmaceutical and nonradioactive items contracted must find alternate supplier for the contracted items. In the event of a manufacturer or pharmacy recall or quality assurance failure, the Contractor shall notify VALLHCS Nuclear Medicine Department immediately. A radio-pharmacist in the employ of the successful Contractor must be available to: Set-up the quality assurance program on the radiopharmaceutical preparations required by Food and Drug Administration (FDA), Nuclear Regulatory Commission (NRC), United States Pharmacopeia (USP), and the Joint Commission. Act as a reference source concerning questions on the regulation of radiopharmaceuticals. Provide reference services for research drugs and radionuclides under research protocols. Provide instruction (continuing education) to the technologists on new changes in radiopharmaceutical products and availability. Contractor to provide FDG bulk dose for MEDRAD system. Contractor able to provide up to 15mCi of 18-FDG for PET patients. Recalled and Defective Products: The Contractor will immediately notify the Contracting Officer of any recalls of product or other important product safety issues. As appropriate, the Contractor will replace and/or reimburse recalled / defective products at no cost to the Government. The Contractor may be liable for costs of processing recalls, i.e. administrative and clinical services to replace recalled / defective products. Certification and Licensing Requirement: Pharmacists employed by the Contractor shall be an authorized user on the Contractor s Radioactive Materials License. The Pharmacy of the Contractor shall be licensed by the State of Operation and by the Nuclear Regulatory Commission or Agreement State Agency. Safety Guidelines and Requirements: Delivery personnel shall be trained in Radiation Safety Techniques, Nuclear Regulatory Commission, Joint Commission safety guidelines and Department of Transportation requirements. National Holidays Observed by the Government: New Year s Day January 1 Martin Luther King s Birthday 3rd Monday in January Presidents Day 3rd Monday in February Memorial Day Last Monday in May Juneteenth Day 3rd Monday in June Independence Day July 4 Labor Day 1st Monday in September Columbus Day 2nd Monday in October Veterans Day November 11 Thanksgiving Day 4th Thursday in November Christmas Day December 25th The President of the United States of America may declare additional days as a Federal holiday, and if so, this holiday will automatically be added to the list above. When a holiday falls on a Sunday, the following Monday shall be observed as a Federal holiday. When a holiday falls on a Saturday, the preceding Friday shall be observed as a Federal Holiday. Contractor Delivery Personnel: All contractor personnel are required to wear clothing bearing the name of the Contractor and wear a badge that has the Contractor name. Contractor personnel must have a picture I.D. and must be able to speak English. Parking and Speed Limit: Park only in areas designated by the Point of Contact (POC) or otherwise directed by Police and Security Service personnel. The Contractor shall display on each of its vehicles the company name in a size that is clearly visible. Upon receipt of award, the Contractor shall submit a list of employees and vehicles to the POC of each facility. The Contractor shall conform to the speed limit set at each Government facility. Should Contractor personnel receive a citation for parking, speeding or other infraction from VA Security, the offenses will be handled in Federal Court as they are Federal offenses. Placement of Verbal Orders: Contractors shall provide on a separate sheet of paper, the name, location, and telephone number of the office where the participating VA facility will call to place orders. The sheet of paper will go to the Point of Contact (POC) or alternative Point of Contact (POC). Invoice and Payment: No advanced payments will be authorized. The contractor shall submit invoices on a monthly basis. The invoice must have at a minimum, the contract number, assigned purchase order, assigned obligation number, date order was placed, date order was shipped, and any additional necessary detailed information to identify service rendered. Payment on invoice may be delayed in invoice(s) are not completed properly. Personnel Policy: The parties agree that the contract personnel working this contract shall not be considered VA employees for any purpose and shall be considered employees of the contractor. Smoking Policy: Smoking is prohibited at our facility. Security Requirements: The C&A requirements do not apply, and that Security Accreditation Package is not required. If your company is interested and capable of providing the required supplies/services, please provide the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions: (1) Submit your capabilities statement illustrating how your organization can/cannot meet the list of SOW requirements. For instances where your company cannot meet the SOW requirement(s), please explain. For instances where your company can meet the SOW requirement(s), please show how your company meets/exceeds each requirement. (2) Please review the list of SOW requirements and provide any additional feedback or suggestions. If none, please reply as N/A. (3) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc. (4) Is your company considered small under the NAICS code identified in this RFI? (5) Are you the manufacturer, authorized distributor, and/or can your company provide a solution to the required supplies/services described in the list of SOW? (6) If you are a large business, do you have any designated/authorized distributors? If so, please provide their company name, telephone, point of contact and size status (if available). (7) If you re a small business and you are an authorized distributor/reseller for the items identified above, do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified. (8) Limitations on Subcontracting: How does your business ensure compliance with the limitations on subcontracting as outlined in 13 CFR § 125.6? (9) Are the items you are identifying/providing considered Commercial of the Shelf (COTS) items as defined in FAR Part 2.101 under commercial items? (10) Non-Manufacturer Rule: If applicable, can you confirm your business complies with the Non-Manufacturer rule? Specifically, does your company: Provide a product from a small business manufacturer or processor? Not exceed 500 employees? Primarily engage in the retail or wholesale trade and normally sell the type of item being supplied? Take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice? (11) Please indicate whether your product conforms to the requirements of the Buy American Act? (12) What is your lead time to deliver a single unit with all components? Is there scale in lead time with greater quantities? Please elaborate. (13) What is estimated life span of your solution? What support/services does that entail? (14) Does your proposed equipment have FDA clearance? Please specify what FDA clearance(s) have been obtained. (15) Does your organization offer a leasing solution? Please elaborate. (16) Does your company have a Federal Supply Schedule (FSS) GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract? If so, please provide the contract number(s). (17) If you are an FSS GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract holder, are all the items/solutions you are providing information about available on your schedule/contract? Please state if all or some items are available on the contract. (18) General pricing of your products/solution is encouraged. Pricing will be used for the purpose of market research only. It will not be used to evaluate for any type of award. (19) Please provide your SAM.gov Unique Entity ID/Cage Code number. Responses to this notice shall be submitted via email to Hestia.Sim@va.gov. Telephone responses will not be accepted. Responses must be received no later than Friday, November 20, 2026, by 10AM Pacific Local Time. All responses to this Sources Sought/RFI will be used for planning purposes only. Responses to this Sources Sought Notice / RFI are not considered a request to be added to a prospective bidders list or to receive a copy of the solicitation. If further RFIs and/or a solicitation or other announcement is issued as a result of the information provided from this RFI, all interested parties must respond to the specific posting separately IAW the specifications of that announcement.
73%
Market Research11/20/2026
THIS REQUEST FOR INFORMATION (RFI) / SOURCES SOUGHT NOTICE IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES. THIS IS NOT A SOLICITATION. SUBMISSION OF INFORMATION ABOUT PRICING, DELIVERY, THE MARKET, AND CAPABILITIES IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI FOR PLANNING PURPOSES IN ACCORDANCE WITH (IAW) FAR 15.201(e). DISCLAIMER This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. SOURCES SOUGHT/RFI DESCRIPTION This is NOT a solicitation announcement. This is a Sources Sought Notice / RFI only. The purpose of this Sources Sought Notice / RFI is to gain information about potential qualified sources and their size classification relative to NAICS 325412 (size standard of 1,300 Employees). Responses to this Sources Sought Notice / RFI will be used by the Government to make appropriate acquisition decisions. After review of the responses to this Sources Sought Notice / RFI, further RFIs and/or a solicitation or other announcements may be published. The Department of Veterans Affairs (VA) is seeking sources capable of providing Lenalidomide medication in multiple dosage strengths. STATEMENT OF WORK LENALIDOMIDE MEDICATION Introduction The Department of Veterans Affairs requires a Health Service Area (HSA) 5.3 Blanket Purchase Agreement (BPA) for Lenalidomide. Lenalidomide is an oral immunomodulatory medication that treats several types of blood cancers. Contractor is to provide Lenalidomide and deliver to participating HSA 5.3 VA Medical Centers (VAMCs). Participating HSA 5.3 VAMCs: VA Albuquerque Healthcare System (501) 1501 San Pedro Drive SE Albuquerque, NM 87108 VA Long Beach Healthcare System (600) 5901 East 7th Street Long Beach, CA 90822 VA Loma Linda Healthcare System (605) 11201 Benton Street Loma Linda, CA 92357 VA Phoenix Healthcare System (644) 650 E Indian School Road Phoenix, AZ 85012 VA Prescott Healthcare System (649) 500 N. State Highway 89 Prescott, AZ 86313 VA San Diego Healthcare System (664) 3350 La Jolla Village Drive San Diego, CA 92161 VA Tucson Healthcare System (678) 3601 S 6th Avenue Tucson, AZ 85723 VA Greater Los Angeles Healthcare System (691) 11301 Wilshire Blvd Los Angeles, CA 90073 Ordering Participating VA Medical Centers shall place orders through an approved purchase order (PO) per station. An approved purchase order shall be signed by a warranted Contracting Officer (CO). Dispensing: Lenalidomide is under Food and Drug Administration s Risk Evaluation and Mitigation Strategy (REMS) program. The contractor must hold REMS certification to dispense. Schedule of Supplies: Line Item Description 0001 LENALIDOMIDE 2.5MG CAP,ORAL 0002 LENALIDOMIDE 5MG CAP,ORAL 0003 LENALIDOMIDE 10MG CAP,ORAL 0004 LENALIDOMIDE 15MG CAP,ORAL 0005 LENALIDOMIDE 20MG CAP,ORAL 0006 LENALIDOMIDE 25MG CAP,ORAL Station Estimated number of patients on FY 26 501 14 600 27 605 18 644 32 649 13 664 28 678 30 691 26 There is not a contractual statement of precise quantities that the Government will order under this BPA. The Government will only pay for quantities that are actually ordered and for which services are fulfilled of each delivery order per station. Above estimated number for patients is based on historical data from previous years. As the required dosage will vary depending on individual patient and provider decisions, the Government is unable to specify the exact quantity needed for each dosage. The contractor is to provide pricing for all dosage strengths, and each station will place orders as needed at the prices negotiated under this contract. Period of Performance: 1-year after award Delivery: The contractor shall be responsible for the delivery of medication to specified location upon ordering in accordance with the requirements outlined. The medication should be provided in the required quantities and formulation as specified. The contractor must ensure proper handling, storage, and transportation conditions (temperature control if required) of the medication to maintain its integrity and compliance with all applicable regulations. Payments: Payments shall be made upon delivery and acceptance by individual medical centers. The contractor shall use the purchase order (PO) number when submitting for payment through Tungsten network website https://portal.tungsten-network.com. The list of DRAFT characteristics is intended to be descriptive, not restrictive, of the supplies/services that are required. If your company is interested and capable of providing the required supplies/services, please provide the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions: (1) Submit your capabilities statement illustrating how your organization can/cannot meet the list of SOW requirements. For instances where your company cannot meet the SOW requirement(s), please explain. For instances where your company can meet the SOW requirement(s), please show how your company meets/exceeds each requirement. (2) Please review the list of SOW requirements and provide any additional feedback or suggestions. If none, please reply as N/A. (3) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran-Owned Small Business (SDVOSB), Veteran-Owned Small Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc. (4) Is your company considered small under the NAICS code identified in this RFI? (5) Are you the manufacturer, authorized distributor, and/or can your company provide a solution to the required supplies/services described in the list of SOW? (6) If you are a large business, do you have any designated/authorized distributors? If so, please provide their company name, telephone, point of contact and size status (if available). (7) If you re a small business and you are an authorized distributor/reseller for the items identified above, do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified. (8) Limitations on Subcontracting: How does your business ensure compliance with the limitations on subcontracting as outlined in 13 CFR § 125.6? (9) Are the items you are identifying/providing considered Commercial of the Shelf (COTS) items as defined in FAR Part 2.101 under commercial items? (10) Non-Manufacturer Rule: If applicable, can you confirm your business complies with the Non-Manufacturer rule? Specifically, does your company: Provide a product from a small business manufacturer or processor? Not exceed 500 employees? Primarily engage in the retail or wholesale trade and normally sell the type of item being supplied? Take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice? (11) Please indicate whether your product conforms to the requirements of the Buy American Act? (12) What is your lead time to deliver a single unit with all components? Is there scale in lead time with greater quantities? Please elaborate. (13) What is estimated life span of your solution? What support/services does that entail? (14) Does your proposed equipment have FDA clearance? Please specify what FDA clearance(s) have been obtained. (15) Does your organization offer a leasing solution? Please elaborate. (16) Does your company have a Federal Supply Schedule (FSS) GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract? If so, please provide the contract number(s). (17) If you are an FSS GSA/NAC/SAC/BPA/NASA SEWP or any other Federal Government contract holder, are all the items/solutions you are providing information about available on your schedule/contract? Please state if all or some items are available on the contract. (18) General pricing of your products/solution is encouraged. Pricing will be used for the purpose of market research only. It will not be used to evaluate for any type of award. (19) Please provide your SAM.gov Unique Entity ID/Cage Code number. Responses to this notice shall be submitted via email to Hestia.Sim@va.gov. Telephone responses will not be accepted. Responses must be received no later than Friday, November 12, 2026, by 10AM Pacific Local Time. All responses to this Sources Sought/RFI will be used for planning purposes only. Responses to this Sources Sought Notice / RFI are not considered a request to be added to a prospective bidders list or to receive a copy of the solicitation. If further RFIs and/or a solicitation or other announcement is issued as a result of the information provided from this RFI, all interested parties must respond to the specific posting separately IAW the specifications of that announcement.
73%
Market Research11/12/2026

Additional Details

Solicitation Number

36C26226Q0072

Archive Date

Jan 9, 2026

Office Address

Gilbert, AZ, 85297